Search Results 611-620 of 14886 for Telangiectasia

  1. Vascular centers - Doctors - Mayo Clinic

    Learn about the expertise and services at Mayo Clinic vascular centers for adults and children with conditions of the blood vessel and lymphatic systems.

  2. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  3. Tonsil cancer - Doctors and departments - Mayo Clinic

    Find out how healthcare teams use innovative treatments such as transoral robotic surgery and proton therapy to treat this type of throat cancer.

  4. Colon cancer prevention: What you can do - Mayo Clinic

    Colon cancer is a common and serious disease around the world. But it also is one of the most preventable cancers. The tools for prevention are widely ...

  5. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

  6. Deep vein thrombosis (DVT) - Doctors and departments - Mayo Clinic

    This potentially serious condition can occur with few or no symptoms. Know the risk factors.

  7. Adult health Eye care - Mayo Clinic

    Maintaining good health. When you think of adult health, you may think about ways to stay healthy. They might include doing all you can to prevent cancer, ...

  8. Klippel-Trenaunay syndrome - Doctors and departments - Mayo Clinic

    Main signs of this congenital disorder involve a red birthmark (port-wine stain), vein malformations, and overgrowth of tissues and bones.

  9. Tonsil cancer - Doctors and departments - Mayo Clinic

    Find out how healthcare teams use innovative treatments such as transoral robotic surgery and proton therapy to treat this type of throat cancer.

  10. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

    A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.